clinical results are conflicting. Chesney e t al.(New Eng.J.Med.,1978)reporta:! increa sed growth velocity in uremic children treated by 1.25 (OH),D, who had failed to respond to high dosage D,.The present study was designed to compare the efficacy of D, and 1.25(0H),D,(application i.p.;3-point dose response curve) on growth in rats with EU. Methods: 909 SpraqueDawley rats with stable uremia(2-stage subtotal nephrectomy) of 2 weeks' duration(C 18% of normal). All animals fed ad lib. Five groups: I: 65 solvent; I1 and 111: NX+D, (0.5 and 1.0 ug/70g/day); IV and ' I : NX+l,25(OH),D,( 0.625 snd1.25 ng/70g/day). Results: Serum Ca increased (p<0.01) to the same extend in NX+D, and NX+1 .25 (OH), D, . Compared to N X solvent animals(5.9+0.2cm/14 days;21+5g/14 days,n=14), the growth rate was significantly better in NX+D,(6.4+ 0.3cm/14 days;31+69/14 days;n=12) and in NX+1.25(0~),~, (6.6+0.3cm/14 days; 32+6 9/14 days;n=12 These data auggest that this early rickets was from maternal reabsorption and decreased fractional clearance (before origin. treatment: 34 and 39%, after treatment: 8 and 12% respectively). In the patient with idiopathic Fanconi syndrome, 1,25(OH)2CC increased Pi filtered load and absolute tubular reabsorption but the fractional clearance did not change. This strongly suggests 2 different pathophysiological mechanisms responsible for the renal tubular loss of Pi. In the 3 patients, 1,25(OH)2CC markedly improved the bone lesions. Medizinische-und Kinderklinik der Universiat Heidelber9,F.R.G. Effect of somatotropin(STH), roid hormone (PTH) and calcitonin (CT) on CAMP-content 0% growth cartilage in uremia.
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C. MALLET, M. GARABEOIANT J.P. BASUYAUT Oept de Pediat r i e . Hbp. Charles N i c o l l e , ROUEN and INSERF; U 30, Hop. des Enfants Malades. PARIS (FRANCE). EVALUATION OF THE INHIBIrORY EFFECT OF VITAMIN D FIETFBOLITES OFI CIRCULATING TFIFIUNOREAC. TIVE PARATHYROID HORMONE (IPTH) I N INFANTILE NUTRITIONAL RICKETS :
STUDY OF VARIATIONS OF SERUY IPTtI AN0 24.25 and 1.25 DIHVOROXYCHOLE-CALCIFEROL LEVELS AFTER 25 HYDLOXYCHOLECALCIFEROL ADMINISTRATION (25 HCC). Recent works have demonstrated an e s s e n t i a l l y i n h i b i t o r y e f f e c t o f vitamin D on IPTH secretion. We present an i n vivo study, c a r r i e d out i n r i c k e t p a t i e n t s , i n an artempt t o confirm previous observations and also contribute t o a b e t t e r physiopathological understanding o f t h i s a f f e c t i o n . 13 and 23 months o l d advanced n u t r i t i o n a l r i c k e t s p a t i e n t s who presented hypocalcemia and hypophosphoramia werq i n i t i a l l y t r e a t e d exclusively
Retardation of growth is a well known feature in uremic children.There is considerable evidence that seveml hormone systems,which play an important role in normal growth,e.g.STH,PTH are altered in uremia.Adenylate cyclase mediates the action of most of these hormones on cell proliferation in the chondrocytes.The effects of STH,PTH and CT on cAMP content of cartilage was investigated. Methods:Male Wistar rats(60gBW)were bilaterally nephretomized(NX)or sham-operated(S0)24h before sacrifice.Bovine STH(6h1,PTH and CT(15min) was given i.v. cAMP in cartilage was measured by RIA. Results: Basal cAMP content in cartilage was not different between NX and SO. Stimulation with 40IU i.v.PTH caused a significantly(~ 0.Ol)lower cAMP increment in NX(11.4+1.0;SEM; n=20)than in S0(24.0+2.6).CT(2.5U)administration resulted in higher cAMP in NX(23.8+1.8;n=19)vs.S0(16.6+1.6). STH(O.l-5.14)was without effect on cAMP in NX or S0,but enhanced 'Thymidine incorporation. Discussion: Target organ resistance to PTH seems to be reflected by diminished CAMP response in uremic growth cartilage.CT has the opposite effect on NX.In the above mode1,with the dose of STH used,no effect on cAMP could be seen.0ur p r e sent results provide evidence that in acute uremia the cAMP system may be involved in the growthatnomlity of RF.
